An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Traction Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.
Several professionals said the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, prosecution or prison.
Platform Response and Content Removal
Based on the social media company, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The company said it was dedicated to keeping the service safe and investing in enhancing compliance measures.
Digital Marketplace Operations
Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, populated with images of slimming results, positive reviews and step-by-step guides for preparing or administering at home.
Within moments of joining one community, a vendor posted contact information, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.
Product Details and Pricing
Inside these groups, posts display black plastic packages with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service said it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered patients injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet authorized … may subject patients to possibly serious health risks”.
